We also examined the levels of active NF-κB and AKT, which are also TLR4 effectors (Doyle et al., 2011; Zhang et al., 2017b) and often activated in skeletal muscle of cancer patients (Zhou et al., 2010; Stephens et al., 2015). This evidence concerns the gene AKT1 and cancer.